What is AGAT?
AGAT (arginine:glycine amidinotransferase, also called GATM) is the enzyme responsible for the first step of endogenous creatine synthesis.
It catalyzes the transfer of an amidino group from arginine to glycine, producing guanidinoacetate (GAA) and ornithine.
This reaction occurs primarily in the kidneys.
AGAT is the rate-limiting enzyme in creatine biosynthesis, meaning it controls how fast your body produces creatine naturally.
The body produces approximately 1-2g of creatine per day through this pathway.
The Biosynthesis Pathway
Creatine synthesis is a two-step process spanning two organs:
- Step 1 (Kidney — AGAT): Arginine + Glycine → Guanidinoacetate (GAA) + Ornithine
- Step 2 (Liver — GAMT): GAA + S-adenosylmethionine → Creatine + S-adenosylhomocysteine
GAA produced by AGAT in the kidneys travels through the bloodstream to the liver, where the GAMT enzyme completes the synthesis by adding a methyl group.
Relevance to Creatine Supplementation
Understanding AGAT helps explain why supplementation is beneficial: endogenous production (1-2g/day) is often insufficient for optimal muscle saturation, especially for athletes and those with higher demands.
Supplementation bypasses the AGAT-GAMT pathway entirely, delivering creatine directly for transport into cells.
Related Terms
- GAMT Enzyme — The second enzyme in creatine biosynthesis
- Creatine Transporter — How creatine enters cells after synthesis
- Creatine Kinase — The enzyme that converts creatine to phosphocreatine
Sources & References
Full citations available in our Research Library.